Professor and Chair, Department of Pediatrics, University of Colorado School of Medicine; Pediatrician-in-Chief, Children's Hospital Colorado
University of Colorado School of Medicine
Aurora, Colorado, United States
Stephen R. Daniels, MD, PhD, MPH is Professor and Chair of the Department of Pediatrics at the University of Colorado School of Medicine, and Pediatrician-in-Chief and L. Joseph Butterfield Chair in Pediatrics at Children’s Hospital Colorado. He received his MD from the University of Chicago; MPH from Harvard University; and PhD in Epidemiology from the University of North Carolina.
Dr. Daniels’ area of expertise is preventive cardiology. His studies focus on understanding causes of blood pressure elevation and cholesterol abnormalities in children and adolescents, particularly the role of obesity. He has researched the development of structural and functional abnormalities in the heart and vascular system, including abnormalities in pediatric patients with diabetes mellitus, as well as the relationship of left ventricular hypertrophy to obesity and hypertension.
Dr. Daniels has served on the Board of Childhood Obesity since 2010. He is co-author of Medical Epidemiology, an introductory textbook for medical students, and co-author and editor of Pediatric Prevention of Atherosclerotic Cardiovascular Disease. He is an Associate Editor for The Journal of Pediatrics. In 2015, he was awarded the Gold Heart Award by the American Heart Association—the AHA’s highest volunteer honor. Dr. Daniels was inducted into the Association of American Physicians in 2021. He has been a member of the Society for Pediatric Research (SPR) and the American Pediatric Society (APS). He served on the APS Nominating Committee from 2015 to 2016, the APS Council from 2017 to 2022, and was voted APS President Elect in 2024.
Saturday, June 29, 2024
3:00 PM – 4:30 PM CT
Disclosure(s): No relevant financial relationship(s) with ineligible companies to disclose.
Saturday, June 29, 2024
3:10 PM – 4:00 PM CT
Disclosure(s): No relevant financial relationship(s) with ineligible companies to disclose.